Welcome to our dedicated page for Riv Capital news (Ticker: CNPOF), a resource for investors and traders seeking the latest updates and insights on Riv Capital stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Riv Capital's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Riv Capital's position in the market.
Canopy Rivers Inc. (OTC: CNPOF) held its annual general and special meeting on September 24, 2020, where 89.1% of shares were represented. Shareholders approved all resolutions, including the election of Garth Hankinson to the Board of Directors. Asha Daniere was appointed Chair of the Board. Hankinson, CFO of Constellation Brands, was welcomed for his finance and M&A expertise. This meeting marks a strategic governance shift aimed at strengthening the company’s operations and shareholder value in the cannabis sector.
Canopy Rivers Inc. (OTC: CNPOF) will hold its annual general and special meeting of shareholders on September 24, 2020, at 10 a.m. EDT. Due to COVID-19 health concerns, the Company encourages shareholders to vote by proxy, limiting physical attendance. Only registered shareholders and proxyholders can attend, with options to ask questions via phone or webcast. An audio replay will be available until October 24, 2020. Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies, aiming to foster growth and create value in the cannabis industry.
Canopy Rivers has announced its Q1 2021 financial results, showing a nominal net operating loss of $2.4 million. The company formed a Special Committee to oversee its investment in PharmHouse amidst liquidity concerns. It has made a strategic investment in Dynaleo, enhancing its presence in the cannabis 2.0 market. Operating expenses decreased significantly by approximately 16% year-over-year, while total comprehensive income rose to $7.3 million. The company's focus remains on operational ramp-up and monetization opportunities within its portfolio.